Details
The Foot in Diabetes
Practical Diabetes 5. Aufl.
134,99 € |
|
Verlag: | Wiley-Blackwell |
Format: | EPUB |
Veröffentl.: | 09.04.2020 |
ISBN/EAN: | 9781119445838 |
Sprache: | englisch |
Anzahl Seiten: | 568 |
DRM-geschütztes eBook, Sie benötigen z.B. Adobe Digital Editions und eine Adobe ID zum Lesen.
Beschreibungen
<p>Fully revised and updated edition of this popular book, addressing all issues concerning the diabetic foot, one of the most prevalent problems in diabetes, with a strong emphasis on practical aspects of delivering care.</p>
<p>List of Contributors xv</p> <p>Preface xix</p> <p>Introduction xxi</p> <p><b>1 Epidemiology and Economic Impact of Foot Ulcers </b><b>1<br /></b><i>Edward J. Boyko and Matilde Monteiro-Soares</i></p> <p>1.1 Introduction 1</p> <p>1.2 Diabetic Foot Ulcer (DFU) Definition 1</p> <p>1.3 DFU Classification 2</p> <p>1.4 DFU Incidence and Prevalence 3</p> <p>1.5 DFU Recurrence 5</p> <p>1.6 Risk Factors for Diabetic Foot Ulcers and Lower Extremity Amputation 6</p> <p>1.7 Diabetic Foot Ulcer Outcomes 7</p> <p>1.8 Economic Considerations 9</p> <p>Reference 10</p> <p><b>2 Cost of Diabetic Foot Disease in England </b><b>17<br /></b><i>Marion Kerr</i></p> <p>2.1 Introduction 17</p> <p>2.2 Human Costs 17</p> <p>2.3 Financial Costs 20</p> <p>2.4 Why Measure Costs? 22</p> <p>2.5 Establishing Healthcare Priorities 22</p> <p>2.6 Conclusions 25</p> <p>References 26</p> <p><b>3 Epidemiology of Amputation and the Influence of Ethnicity </b><b>31<br /></b><i>Caroline A. Abbott</i></p> <p>3.1 Why Study the Epidemiology of LEA? 31</p> <p>3.2 LEA Incidence Study Design: The Risk of Bias 32</p> <p>3.3 LEA Risk Assessment Study Design 32</p> <p>3.4 Risk Factors for LEA 33</p> <p>3.5 Incidence Rates of LEA 34</p> <p>3.6 International and Regional Differences 34</p> <p>3.7 Time Trends in LEA Rates 34</p> <p>3.8 Ethnic Differences in Diabetes-Related LEA 35</p> <p>3.9 Ethnic Differences in Diabetes-Related LEA Risk 35</p> <p>3.10 Indian Asians 38</p> <p>References 38</p> <p><b>4a The Diabetic Foot Worldwide: India </b><b>43<br /></b><i>M. Viswanathan</i></p> <p>4a.1 Introduction 43</p> <p>4a.2 Epidemiology of Diabetes in India 43</p> <p>4a.3 Socio Economic Burden Due to Diabetes 43</p> <p>4a.4 Common Risk Factors for Amputation in India 43</p> <p>4a.5 Diagnosing High Risk Feet in Developing Countries 44</p> <p>4a.6 Comparison in Risk Factors between India and the Western World 44</p> <p>4a.7 DFI as a Cause for Declining Kidney Function 44</p> <p>4a.8 Helping People with Amputation Cope Up with the Disability 44</p> <p>References 45</p> <p><b>4b The Diabetic Foot Worldwide: Pakistan </b><b>47<br /></b><i>Abdul Basit</i></p> <p>4b.1 Introduction 47</p> <p>4b.2 Concept of Multidisciplinary Diabetic Foot Care Team (MDFCT) 47</p> <p>4b.3 Nationwide Diabetic Foot Programme (Step by Step-[SbS]) 48</p> <p>4b.4 Footwear for Every Diabetic (FED) 48</p> <p>4b.5 Further Steps Ahead of SbS 49</p> <p>References 49</p> <p><b>4c The Diabetic Foot Worldwide: Sub-Saharan Africa </b><b>51<br /></b><i>Zulfiqarali G. Abbas</i></p> <p>4c.1 Introduction 51</p> <p>4c.2 Pathophysiology of Foot Ulcers 52</p> <p>4c.3 Peripheral Neuropathy (PN) 52</p> <p>4c.4 Peripheral Arterial Diseases (PAD) 53</p> <p>4c.5 Foot Ulceration in SSA 54</p> <p>4c.6 Foot Infection 55</p> <p>4c.7 Amputation 56</p> <p>4c.8 Mortality 56</p> <p>4c.9 Prevention 56</p> <p>4c.10 Conclusions 58</p> <p>References 58</p> <p><b>4d Burden of Diabetic Foot Disease in Brazil </b><b>61<br /></b><i>Hermelinda C. Pedrosa and Luciana R. Bahia</i></p> <p>References 64</p> <p><b>4e Diabetic Foot in Romania and Eastern Europe </b><b>67<br /></b><i>Norina Alinta Gâvan and C. I. Bondor</i></p> <p>4e.1 Introduction 67</p> <p>4e.2 The Aim 67</p> <p>4e.3 Diabetic Foot in Romania 67</p> <p>4e.4 Diabetic Foot in Eastern Europe 70</p> <p>4e.5 Conclusions 71</p> <p>References 71</p> <p><b>4f Diabetic Foot Worldwide: Pacific Region </b><b>75</b></p> <p><i>Shigeo Kono</i></p> <p>References 76</p> <p><b>4g The Diabetic Foot Worldwide: Middle East </b><b>79<br /></b><i>Samir H. Assaad-Khalil</i></p> <p>4g.1 The Burden of Diabetic Foot Disease (DFD) in the Middle East (ME) 79</p> <p>4g.2 Specific Regional Barriers to Healthy Feet and Foot Care 80</p> <p>4g.3 Misconceptions 81</p> <p>4g.4 Footwear 81</p> <p>4g.5 Foot Care, Education and Awareness 81</p> <p>References 82</p> <p><b>4h The Diabetic Foot Worldwide: Australasia </b><b>85<br /></b><i>Peter A. Lazzarini</i></p> <p>4h.1 Introduction 85</p> <p>4h.2 Australia 85</p> <p>4h.3 New Zealand 86</p> <p>4h.4 Pacific Islands 86</p> <p>4h.5 Conclusion 87</p> <p>References 87</p> <p><b>5 Diabetic Neuropathy </b><b>89<br /></b><i>Dinesh Selvarajah, Gordon Sloan, and Solomon Tesfaye</i></p> <p>5.1 Epidemiology 89</p> <p>5.2 Classification 89</p> <p>5.3 Symmetrical Neuropathies 91</p> <p>5.4 Asymmetrical Neuropathies 95</p> <p>5.5 Pathogenesis of Distal Symmetrical Neuropathy 97</p> <p>5.6 Management of Diabetic Neuropathy 98</p> <p>References 101</p> <p><b>6 The Pathway to Ulceration: Aetiopathogenesis and Screening </b><b>105<br /></b><i>Andrew J.M. Boulton</i></p> <p>6.1 Introduction 105</p> <p>6.2 Peripheral Arterial Disease (PAD) 106</p> <p>6.3 Diabetic Neuropathy 107</p> <p>6.4 Neuropathy: The Major Contributory Factor in Ulceration 109</p> <p>6.5 Other Risk Factors for Foot Ulceration 109</p> <p>6.6 Assessment of Foot Ulcer Risk 111</p> <p>6.7 The Pathway to Ulceration 116</p> <p>6.8 Mechanical Factors and Neuropathic Foot Ulceration 118</p> <p>6.9 The Patient with Sensory Loss 120</p> <p>References 120</p> <p><b>7 Biomechanics of the Diabetic Foot for the Uninitiated </b><b>125<br /></b><i>S.A. Bus and J.S. Ulbrecht</i></p> <p>7.1 Introduction 125</p> <p>7.2 The Concept of Pressure and its Measurement 125</p> <p>7.3 The Role of Elevated Plantar Pressure in Foot Ulceration 126</p> <p>7.4 Mechanisms of Elevated Plantar Pressure 128</p> <p>7.5 Foot Biomechanics in Treating a Plantar Foot Ulcer 130</p> <p>7.6 Biomechanical Issues in Preventing a Foot Ulcer 132</p> <p>7.7 Summary 133</p> <p>References 134</p> <p><b>8 Psychological and Behavioural Aspects of Diabetic Foot Ulceration </b><b>139<br /></b><i>Loretta Vileikyte and Ryan T. Crews</i></p> <p>8.1 The Role of Psychological and Behavioural Factors in DFU Development 139</p> <p>8.2 The Role of Psychological and Behavioural Factors in DFU Healing 142</p> <p>8.3 The Impact of DFUs on Patients’ Health Status and QoL 146</p> <p>8.4 Measuring QoL in DFU Patients: Generic, DFU-Specific or Combined Approach? 147</p> <p>References 148</p> <p><b>9 What Role for the Plain Radiograph of the Diabetic Foot? </b><b>153<br /></b><i>Richard William Whitehouse</i></p> <p>9.1 Introduction 153</p> <p>9.2 Pathologies 157</p> <p>9.3 Summary 166</p> <p>References 167</p> <p><b>10 Advanced Cross-Sectional Radiology-Ultrasound, Computed Tomography and Magnetic Resonance Imaging of the Diabetic Foot </b><b>169<br /></b><i>Aparna Komarraju and Avneesh Chhabra</i></p> <p>10.1 Introduction 169</p> <p>10.2 Pathophysiology of Diabetic Foot Disease 170</p> <p>References 183</p> <p><b>11 Gait and Exercise Training in Diabetic Peripheral Neuropathy </b><b>187<br /></b><i>Neil D. Reeves</i></p> <p>11.1 Introduction 187</p> <p>11.2 Gait Characteristics of People with Diabetes 187</p> <p>11.3 Muscle Forces and the Biomechanics of Gait in Diabetes 188</p> <p>11.4 Biomechanical Strategies to Alter Gait in Diabetic Peripheral Neuropathy 190</p> <p>11.5 Falls and Diabetic Peripheral Neuropathy 193</p> <p>11.6 Biomechanical Factors Leading to Increased Fall Risk 193</p> <p>11.7 Diabetic Peripheral Neuropathy and Balance during Gait 194</p> <p>11.8 Exercise and Diabetic Peripheral Neuropathy 196</p> <p>11.9 Effects of Exercise in Patients with Diabetic Peripheral Neuropathy on Gait and Balance 197</p> <p>11.10 The Case for Resistance Exercise Training 198</p> <p>References 198</p> <p><b>12 Smart Technology for the Diabetic Foot in Remission </b><b>201<br /></b><i>Bijan Najafi and David G. Armstrong</i></p> <p>12.1 Background 201</p> <p>12.2 Technologies to Guide the Prescription of Footwear-Related Offloading Treatments 203</p> <p>12.3 Technologies to Facilitate Triaging those at High Risk of DFU 204</p> <p>12.4 Technologies to Manage Dose of Physical Activities in People with Diabetes and Insensate Foot 211</p> <p>12.5 Using Technology to Improve Patient Education for Effective Prevention of Diabetic Foot Ulcers 214</p> <p>12.6 Mobile Health (mHealth) to Manage Diabetic Foot Ulcers 215</p> <p>12.7 Internet of Things and Remote Management of Diabetic Foot Ulcers 216</p> <p>12.8 Technologies to Facilitate Delivering of Therapy at Home and Reduce Risk of DFU 217</p> <p>12.9 Conclusion 218</p> <p>References 219</p> <p><b>13 How to Assess the Quality of Clinical Trials for Diabetic Foot Ulcer Therapies </b><b>225<br /></b><i>Fran Game and William Jeffcoate</i></p> <p>13.1 Introduction 225</p> <p>13.2 Hierarchy of Evidence 226</p> <p>13.3 Items to Be Considered in Assessing Trials of Diabetic Foot Ulcer Therapies 227</p> <p>13.4 The Population 227</p> <p>13.5 The Person and Limb 228</p> <p>13.6 The Ulcer 229</p> <p>13.7 The Therapy 230</p> <p>13.8 Outcomes 230</p> <p>13.9 Adverse Events 231</p> <p>13.10 21 Point Checklist 231</p> <p>References 233</p> <p><b>14a Bypass in Diabetic Peripheral Artery Disease </b><b>235<br /></b><i>Neal R. Barshes and Joseph L. Mills</i></p> <p>14a.1 Identifying Significant PAD Amongst Patients Presenting with Foot Ulcers 235</p> <p>14a.2 Relative Benefits and Risks: Identifying Patients Who May Benefit from a Leg Bypass Operation 237</p> <p>14a.3 Evaluating Relevant Vascular Anatomy for Planning a Bypass Operation 239</p> <p>14a.4 The Operation and Early In-Hospital Recovery 241</p> <p>14a.5 Follow-Up After a Leg Bypass Operation 243</p> <p>References 243</p> <p><b>14b Surgery or Endovascular Intervention in Diabetic Peripheral Vascular Disease </b><b>247<br /></b><i>Edward Y. Woo and Misaki M. Kiguchi</i></p> <p>14b.1 Introduction 247</p> <p>14b.2 Background 247</p> <p>14b.3 Diagnosis 248</p> <p>14b.4 Management 250</p> <p>14b.5 Endovascular Revascularization 250</p> <p>14b.6 Results 253</p> <p>14b.7 Complications 254</p> <p>14b.8 Conclusion 254</p> <p>References 255</p> <p><b>15 Inpatient Diabetic Foot Care: A UK Perspective </b><b>259<br /></b><i>Gerry Rayman</i></p> <p>15.1 Introduction 259</p> <p>15.2 The Burden of Inpatient Diabetes 260</p> <p>15.3 The Burden of Inpatient Diabetic Foot Disease 260</p> <p>15.4 Recommended Foot Care for Inpatients with Diabetes 261</p> <p>15.5 Summary 262</p> <p>References 263</p> <p><b>16 Diagnosis and Management of Infection in the Diabetic Foot </b><b>265<br /></b><i>Edgar J.G. Peters and Benjamin A. Lipsky</i></p> <p>16.1 Introduction 265</p> <p>16.2 Pathophysiology of Infections in Persons with Diabetes Mellitus 265</p> <p>16.3 Risk Factors for DFI 266</p> <p>16.4 Clinical Signs and Symptoms 266</p> <p>16.5 Classification 267</p> <p>16.6 Microbiology 268</p> <p>16.7 Treatment 269</p> <p>16.8 IWGDF Grade 4 (Severe) Infections 274</p> <p>16.9 Osteomyelitis 275</p> <p>References 280</p> <p><b>17 Surgical Approach to Diabetic Foot Infections </b><b>287<br /></b><i>Katherine M. Raspovic, Javier La Fontaine, and Lawrence Lavery</i></p> <p>17.1 Introduction 287</p> <p>17.2 Initial Evaluation 288</p> <p>17.3 Initial Surgical Intervention 290</p> <p>17.4 After Initial Surgical Intervention 293</p> <p>17.5 Staged Surgical Intervention and Wound Closure 294</p> <p>17.6 Surgical Offloading 296</p> <p>17.7 Soft Tissue/Tendon Balancing and Definitive Osseous Surgical Reconstruction 296</p> <p>17.8 Decision for Proximal Level Amputation 297</p> <p>17.9 Conclusions 298</p> <p>References 298</p> <p><b>18 The Evidence Base for the Choice of Dressings in the Management of Diabetic Foot Ulcers </b><b>301<br /></b><i>William J. Jeffcoate, Patricia E. Price, and Frances L. Game</i></p> <p>18.1 The Problems 301</p> <p>18.2 Quality of Evidence 302</p> <p>18.3 The Definition of a Dressing 302</p> <p>18.4 The Roles of the Dressing 303</p> <p>18.5 Basic Aspects of Wound Care 304</p> <p>18.6 Evidence for Potential Contributions of Dressings and Wound Applications to Improve Wound Healing 304</p> <p>18.7 Other Therapies which May Modulate Healing of Chronic Wounds 306</p> <p>18.8 Summary 307</p> <p>References 308</p> <p><b>19 Pathogenesis of Charcot Neuroarthropathy and Acute Management </b><b>311<br /></b><i>N.L. Petrova and Michael E. Edmonds</i></p> <p>19.1 Introduction 311</p> <p>19.2 Pathogenesis of CN 311</p> <p>19.3 Acute Management of CN 316</p> <p>19.4 Conclusions 318</p> <p>References 319</p> <p><b>20 Surgical Reconstruction of the Charcot Foot </b><b>323<br /></b><i>George Liu, Katherine Raspovic, and Dane Wukich</i></p> <p>20.1 Introduction 323</p> <p>20.2 Indications for Surgical Reconstruction 323</p> <p>20.3 Radiographic Predictors for Ulceration 325</p> <p>20.4 Timing of Surgery 326</p> <p>20.5 Preoperative Medical Workup 327</p> <p>20.6 Glycemic Control 327</p> <p>20.7 Vitamin D 328</p> <p>20.8 Renal Function 328</p> <p>20.9 Procedures/Outcome Studies 328</p> <p>20.10 Outcomes of Charcot Reconstruction 334</p> <p>20.11 Summary of Evidence Based Recommendations 335</p> <p>References 336</p> <p><b>21 Amputation in the Diabetic Foot </b><b>345<br /></b><i>Michael S. Pinzur and Adam P. Schiff</i></p> <p>21.1 Introduction 345</p> <p>21.2 Impediments to Rehabilitation in the Diabetic Amputee 345</p> <p>21.3 The Lower Extremity as an Organ of Weight Bearing 346</p> <p>21.4 Metabolic Cost of Walking with an Amputation 346</p> <p>21.5 Limb Salvage vs. Amputation 347</p> <p>21.6 Amputation Level Selection 348</p> <p>21.7 The Terminal Organ of Weight Bearing 348</p> <p>21.8 The Soft Tissue Envelope 351</p> <p>21.9 Tissue Management 351</p> <p>21.10 Outcomes Following Amputation 352</p> <p>21.11 Surgical Amputation Levels 352</p> <p>21.12 Lesser Toe Amputation 353</p> <p>21.13 Ray Resection 353</p> <p>21.14 Midfoot Amputation 355</p> <p>21.15 Hindfoot Amputation 355</p> <p>21.16 Symes’s Ankle Disarticulation Amputation 356</p> <p>21.17 Transtibial Amputation 357</p> <p>21.18 Knee Disarticulation Amputation 359</p> <p>21.19 Transfemoral Amputation 359</p> <p>21.20 Conclusions 360</p> <p>References 360</p> <p><b>22 Rehabilitation of the Amputee </b><b>363<br /></b><i>Karen Kowalske and Merrine Klakeel</i></p> <p>22.1 Lower Limb Amputation and Prosthetics 363</p> <p>22.2 Foot Amputations 364</p> <p>22.3 Foot Orthotics 365</p> <p>22.4 Transtibial Amputations 366</p> <p>22.5 Ankle/Foot Components 369</p> <p>22.6 Conclusion 372</p> <p>References 372</p> <p><b>23 Surgery for the Diabetic Foot: Prophylactic and Osteomyelitis Surgery – Is there an Evidence Base? </b><b>375<br /></b><i>Javier Aragón-Sánchez</i></p> <p>23.1 The Role of Surgery Preventing Occurrence and Recurrence of Foot Ulcers 376</p> <p>23.2 Preoperative Care 376</p> <p>23.3 Hallux and First Metatarsal Head Procedures 377</p> <p>23.4 Lesser Toes 380</p> <p>23.5 Lesser Metatarsal Heads 381</p> <p>23.6 Tendon Achilles Lengthening 383</p> <p>23.7 Curative Surgery for Treating Diabetic Foot Osteomyelitis 385</p> <p>23.8 Surgery of Forefoot Osteomyelitis 386</p> <p>23.9 Surgery of Midfoot Osteomyelitis 388</p> <p>23.10 Surgery of Rear Foot Osteomyelitis 388</p> <p>References 389</p> <p><b>24 Footwear and Orthoses for People with Diabetes </b><b>395<br /></b><i>J.S. Ulbrecht and S.A. Bus</i></p> <p>24.1 Introduction 395</p> <p>24.2 What is a Therapeutic Shoe for a Person Living with Diabetes? 395</p> <p>24.3 Who Needs Therapeutic Shoes? 402</p> <p>24.4 Choosing the Appropriate Footwear for the Patient with LOPS 403</p> <p>24.5 Summary and Future Trends 406</p> <p>References 406</p> <p><b>25 The Diabetic Foot in Remission </b><b>409<br /></b><i>Tanzim Khan, Sicco A. Bus, Andrew J.M. Boulton, and David G. Armstrong</i></p> <p>25.1 The Diabetic Foot in Remission 409</p> <p>25.2 Maintaining Remission 410</p> <p>25.3 Conclusion 413</p> <p>References 414</p> <p><b>26 Setting up a Diabetic Foot Clinic </b><b>417<br /></b><i>Michael E. Edmonds and N.L. Petrova</i></p> <p>26.1 Natural History of the Diabetic Foot 417</p> <p>26.2 Principles of Care of the Diabetic Foot 418</p> <p>26.3 Space for the Diabetic Foot Clinic 418</p> <p>26.4 Personnel for the Diabetic Foot Clinic 419</p> <p>26.5 Organisation of the Diabetic Foot Clinic 422</p> <p>26.6 Conclusion 426</p> <p>References 426</p> <p><b>27 National Audit of Diabetic Foot Care: Continuing Audit is Essential for the Delivery of Optimal Care of Diabetic Foot Ulcers </b><b>429<br /></b><i>William Jeffcoate, Gerry Rayman, and Bob Young</i></p> <p>27.1 Why Should We Document the Outcome of Routine Care? 429</p> <p>27.2 General Principles of Clinical Audit 430</p> <p>27.3 National Diabetes Foot Care Audit of England and Wales 433</p> <p>References 437</p> <p><b>28 Regenerative Medicine and the Diabetic Foot </b><b>439<br /></b><i>Zachary A. Stern-Buchbinder, Babak Hajhosseini, and Geoffrey C. Gurtner</i></p> <p>28.1 Introduction 439</p> <p>28.2 Stem Cells 439</p> <p>28.3 Diabetes and Healing Impairment 442</p> <p>28.4 Diabetes and Vascular Dysfunction 443</p> <p>28.5 Functional Heterogeneity of Stem Cells 446</p> <p>28.6 Advances in Regenerative Therapy 447</p> <p>28.7 Conclusion 449</p> <p>References 449</p> <p><b>29 Role of the Plastic Surgeon in Diabetic Foot Care </b><b>457<br /></b><i>Joon Pio (Jp) Hong and Hyunsuk Peter Suh</i></p> <p>29.1 Introduction 457</p> <p>29.2 Multidisciplinary Approach and the Spectrum of Care 458</p> <p>29.3 Reconstruction Algorithm 459</p> <p>29.4 Debridement (this is Covered in Detail in another Chapter) 460</p> <p>29.5 Evaluating and Enhancing the Vascular Status 461</p> <p>29.6 Skin Grafts and Substitutes 462</p> <p>29.7 Local Flaps 463</p> <p>29.8 Free Flaps 464</p> <p>29.9 Amputation 466</p> <p>29.10 Conclusion 467</p> <p>References 469</p> <p><b>30a Algorithms for Diabetic Foot Care: Management of the Hot Swollen Foot </b><b>473<br /></b><i>Michael E. Edmonds, Chris Manu, and Nina Petrova</i></p> <p>References 480</p> <p><b>30b Approach to a New Diabetic Foot Ulceration </b><b>481<br /></b><i>Prashanth R.J. Vas and Michael E. Edmonds</i></p> <p>30b.1 Introduction 481</p> <p>30b.2 Clinical Care for the Management of DFU 482</p> <p>30b.3 Management of DFU 485</p> <p>30b.4 Structural Care Process in DFU Management 490</p> <p>References 491</p> <p><b>30c Algorithms for Diabetic Foot Care: Vascular Evaluation </b><b>495<br /></b><i>G. Dovell and R.J. Hinchliffe</i></p> <p>30c.1 Introduction 495</p> <p>30c.2 Methods of Vascular Evaluation – Detecting Peripheral Artery Disease 496</p> <p>30c.3 Vascular Imaging 498</p> <p>30c.4 Conclusions 500</p> <p>References 503</p> <p><b>30d Algorithms for Diagnosis and Management of Infection in the Diabetic Foot </b><b>507<br /></b><i>Edgar J.G. Peters and Benjamin A. Lipsky</i></p> <p>30d.1 Diagnosis of Infection 507</p> <p>30d.2 Therapy of Infection 509</p> <p>References 514</p> <p>Index 515</p>
<p><b>Professor Andrew J. M. Boulton,</b> Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK; Consultant Physician, Manchester Royal Infirmary, Manchester, UK; Visiting Professor, Diabetes Research Institute, University of Miami, Miami, FL, USA. <p><b>Professor Gerry Rayman,</b> The Diabetes Centre, Ipswich Hospital, Ipswich, UK; University of East Anglia, Norwich, UK; University of Suffolk, Ipswich, UK. <p><b>Dr. Dane K. Wukich,</b> Professor and Chair, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
<p><b>A comprehensive resource that addresses all the issues concerning the diabetic foot</b> <p>The revised fifth edition of <i>The Foot in Diabetes</i> offers an important guide to one of the most prevalent problems in diabetes, with a strong emphasis on practical aspects of delivering care. It contains information on the most recent development in the field of diabetic foot care and its scientific basis. <p>This classic resource continues to reflect the strengths of earlier editions. The contributors noted international panel of experts on the topic stress the practical applications and management of treating the diabetic foot.??All the chapters have been fully revised and updated, with new chapters introduced that cover: <ul> <li>global review of diabetic foot problems</li> <li>new imagining techniques</li> <li>smart technology</li> <li>the use of regenerative medicine</li> <li>providing algorithms for diabetic foot care</li> </ul> <p>Written for all members of the diabetes specialist team including diabetologists, podiatrists, specialist nurses, general practitioners, surgeons and clinical researchers, <i>The Foot in Diabetes, Fifth Edition</i> is the essential resource need to keep abreast of the most recent developments in the field.